chr10-125816436-C-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000375.3(UROS):c.63+1G>A variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.0000291 in 1,614,000 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000375.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- cutaneous porphyriaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| UROS | NM_000375.3 | c.63+1G>A | splice_donor_variant, intron_variant | Intron 2 of 9 | ENST00000368797.10 | NP_000366.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152174Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000239 AC: 6AN: 251480 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.0000267 AC: 39AN: 1461826Hom.: 0 Cov.: 31 AF XY: 0.0000220 AC XY: 16AN XY: 727228 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152174Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74340 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:2
This sequence change affects a donor splice site in intron 2 of the UROS gene. RNA analysis indicates that this variant induces altered splicing and likely results in a shortened protein product. This variant is present in population databases (rs373864821, ExAC 0.01%). This variant has been observed in individual(s) with congenital erythropoietic porphyria (PMID: 7860775, 11254675). ClinVar contains an entry for this variant (Variation ID: 3767). Studies have shown that this variant is associated with skipping of exon 2 and is expected to result in the loss of the initiator methionine (PMID: 7860775). This variant disrupts the p.Val3 amino acid residue in UROS. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9188670, 23626549, 19099412, Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
- -
Cutaneous porphyria Pathogenic:1
- -
UROS-related disorder Pathogenic:1
The UROS c.63+1G>A variant is predicted to disrupt the GT donor site and interfere with normal splicing. This variant was reported in an individual with Porphyria, erythropoietic (IVS2+1 in Xu et al. 1995. PubMed ID: 7860775; Solis et al. 2001. PubMed ID: 11254675). This variant is reported in 0.0070% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/10-127505005-C-T). Variants that disrupt the consensus splice donor site in UROS are expected to be pathogenic. This variant is interpreted as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at